復星醫藥(02196.HK):復星健康擬向台州市立投資轉讓台州浙東醫養投資75%股權 總價5.53億元
格隆匯5月31日丨復星醫藥(02196.HK)公吿,控股子公司復星健康擬向台州市立投資轉讓所持有的台州浙東醫養投資(其主要資產為在建的台州浙東醫院)75%的股權,本次轉讓總價為人民幣5.53億元。
為滿足區域性醫療服務需求、探索醫療康養的新模式,2014年8月經上海復星醫藥(集團)股份有限公司(以下簡稱“復星醫藥”或“公司”)第六屆第三十次董事會審議批准,同意控股子公司上海復星醫療(集團)有限公司(現已更名為上海復星健康科技(集團)有限公司,以下簡稱“復星健康”)與台州市立投資有限公司(以下簡稱“台州市立投資”)簽訂合作協議,由雙方共同投資設立台州市立浙東醫養投資管理有限公司(以下簡稱“台州浙東醫養投資”或“目標公司”),其中:復星健康以現金出資人民幣5.112億元,佔目標公75%的股權;台州市立投資以讚揚院區(座落於台州市椒江區海門街道讚揚區)140.9085畝醫衞慈善用地的土地使用權評估作價人民幣1.7億元入股,佔目標公司25%的股權。截至公吿日,台州浙東醫養投資的主要資產為在建的台州浙東醫院有限公司(以下簡稱“台州浙東醫院”)。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.